310 related articles for article (PubMed ID: 17075495)
1. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
Bourlière M
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
[No Abstract] [Full Text] [Related]
2. [Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
Marcellin P; Lada O
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S5-8. PubMed ID: 17075487
[No Abstract] [Full Text] [Related]
3. [Managing resistance to analogue antiviral drugs in a chronic compensated hepatitis B patient].
Bronowicki JP; Barraud H; Couzigou P
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S17-9. PubMed ID: 17075490
[No Abstract] [Full Text] [Related]
4. [Treatment of lamiduvine-resistant mutant chronic hepatitis B with interferon alpha].
Pariente A; Tachet A; Poveda JD
Gastroenterol Clin Biol; 2002 Nov; 26(11):1059-60. PubMed ID: 12483147
[No Abstract] [Full Text] [Related]
5. [Managing resistance to analogue antiviral drugs in a decompensated cirrhosis patient].
Zarski JP
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S20-1. PubMed ID: 17075491
[No Abstract] [Full Text] [Related]
6. [Definitions of resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
Zoulim F
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S9-11. PubMed ID: 17075488
[No Abstract] [Full Text] [Related]
7. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
Locarnini S; Warner N
Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
[TBL] [Abstract][Full Text] [Related]
8. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
Enomoto M; Tamori A; Kohmoto MT; Morikawa H; Habu D; Sakaguchi H; Takeda T; Seki S; Kawada N; Shiomi S; Nishiguchi S
J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
[TBL] [Abstract][Full Text] [Related]
9. How to overcome antiviral-resistant hepatitis B virus?
Song BC
Intervirology; 2010; 53(1):29-38. PubMed ID: 20068338
[TBL] [Abstract][Full Text] [Related]
10. Current therapy of chronic hepatitis B.
Pardo M; Bartolomé J; Carreño V
Arch Med Res; 2007 Aug; 38(6):661-77. PubMed ID: 17613358
[No Abstract] [Full Text] [Related]
11. Therapy of chronic hepatitis B: today and tomorrow.
Trifan A; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):689-98. PubMed ID: 14756005
[TBL] [Abstract][Full Text] [Related]
12. Combined interferon and lamivudine therapy: is this the treatment of choice for patients with chronic hepatitis B virus infection?
Terrault NA
Hepatology; 2000 Sep; 32(3):675-7. PubMed ID: 10991635
[No Abstract] [Full Text] [Related]
13. [HBV mutations during antiviral therapy in patients with chronic hepatitis B].
Hwang SG
Korean J Hepatol; 2005 Dec; 11(4):311-9. PubMed ID: 16380660
[No Abstract] [Full Text] [Related]
14. Antiviral therapy of chronic hepatitis B.
Zoulim F
Antiviral Res; 2006 Sep; 71(2-3):206-15. PubMed ID: 16716414
[TBL] [Abstract][Full Text] [Related]
15. [Chronic hepatitis B: natural history and treatments].
Bailly F; Zoulim F
Gastroenterol Clin Biol; 2002 May; 26(5):492-500. PubMed ID: 12122361
[No Abstract] [Full Text] [Related]
16. One two tandem of lamivudine and inferferon might work for patients with chronic hepatitis B who failed inferferon monotherapy.
Kaplan DD; Reddy KR
Am J Gastroenterol; 2002 Sep; 97(9):2465-7. PubMed ID: 12358276
[No Abstract] [Full Text] [Related]
17. [Chronic hepatitis B virus infection].
Trifan A; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2003; 107(1):19-27. PubMed ID: 14755965
[TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis B: back to the future with HBsAg.
Moucari R; Lada O; Marcellin P
Expert Rev Anti Infect Ther; 2009 Aug; 7(6):633-6. PubMed ID: 19681689
[No Abstract] [Full Text] [Related]
19. Potential threat of drug-resistant and vaccine-escape HBV mutants to public health.
Teo CG; Locarnini SA
Antivir Ther; 2010; 15(3 Pt B):445-9. PubMed ID: 20516564
[TBL] [Abstract][Full Text] [Related]
20. Treatment of children persistently infected with hepatitis B virus: seroconversion or suppression.
Price N; Boxall EH
J Antimicrob Chemother; 2007 Dec; 60(6):1189-92. PubMed ID: 17913721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
